{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:56:57Z","timestamp":1788991017773,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Liaoning Key R&D Program Project","award":["2020JH2\/10100017"],"award-info":[{"award-number":["2020JH2\/10100017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10495-024-01995-w","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T08:01:34Z","timestamp":1721289694000},"page":"1429-1453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy"],"prefix":"10.1007","volume":"29","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhansheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"issue":"4","key":"1995_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/hep.32195","volume":"75","author":"HZ Zhou","year":"2022","unstructured":"Zhou HZ, Li F, Cheng ST, Xu Y, Deng HJ, Gu DY, Wang J, Chen WX, Zhou YJ, Yang ML, Ren JH, Zheng L, Huang AL, Chen J (2022) DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis. Hepatology (Baltimore MD) 75(4):847\u2013865. https:\/\/doi.org\/10.1002\/hep.32195","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"1995_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13046-023-02893-w","volume":"42","author":"L Zhou","year":"2023","unstructured":"Zhou L, He L, Liu CH, Qiu H, Zheng L, Sample KM, Wu Q, Li J, Xie K, Ampuero J, Li Z, Lv D, Liu M, Romero-G\u00f3mez M, Hu Y, Tang H (2023) Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma. J Experimental Clin cancer Research: CR 42(1):311. https:\/\/doi.org\/10.1186\/s13046-023-02893-w","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"1995_CR3","doi-asserted-by":"publisher","first-page":"154687","DOI":"10.1016\/j.phymed.2023.154687","volume":"112","author":"T Xiao","year":"2023","unstructured":"Xiao T, Bao J, Tian J, Lin R, Zhang Z, Zhu Y, He Y, Gao D, Sun R, Zhang F, Cheng Y, Shaletanati J, Zhou H, Xie C, Yang C (2023) Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT. Phytomedicine: Int J Phytotherapy Phytopharmacology 112:154687. https:\/\/doi.org\/10.1016\/j.phymed.2023.154687","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"issue":"2","key":"1995_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J (2022) Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sinica B 12(2):558\u2013580. https:\/\/doi.org\/10.1016\/j.apsb.2021.09.019","journal-title":"Acta Pharm Sinica B"},{"issue":"9","key":"1995_CR5","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Ren L, Li S, Li W, Zheng X, Yang Y, Fu W, Yi J, Wang J, Du G (2021) The biology, function, and applications of exosomes in cancer. Acta Pharm Sinica B 11(9):2783\u20132797. https:\/\/doi.org\/10.1016\/j.apsb.2021.01.001","journal-title":"Acta Pharm Sinica B"},{"issue":"3","key":"1995_CR6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","volume":"12","author":"S Dong","year":"2022","unstructured":"Dong S, Guo X, Han F, He Z, Wang Y (2022) Emerging role of natural products in cancer immunotherapy. Acta Pharm Sinica B 12(3):1163\u20131185. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.020","journal-title":"Acta Pharm Sinica B"},{"issue":"4","key":"1995_CR7","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.apsb.2021.11.001","volume":"12","author":"T Zhong","year":"2022","unstructured":"Zhong T, Zhang W, Guo H, Pan X, Chen X, He Q, Yang B, Ding L (2022) The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies. Acta Pharm Sinica B 12(4):1761\u20131780. https:\/\/doi.org\/10.1016\/j.apsb.2021.11.001","journal-title":"Acta Pharm Sinica B"},{"issue":"13","key":"1995_CR8","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.7150\/ijbs.70149","volume":"18","author":"Y You","year":"2022","unstructured":"You Y, Wen D, Zeng L, Lu J, Xiao X, Chen Y, Song H, Liu Z (2022) ALKBH5\/MAP3K8 axis regulates PD-L1\u2009+\u2009macrophage infiltration and promotes hepatocellular carcinoma progression. Int J Biol Sci 18(13):5001\u20135018. https:\/\/doi.org\/10.7150\/ijbs.70149","journal-title":"Int J Biol Sci"},{"issue":"30","key":"1995_CR9","doi-asserted-by":"publisher","first-page":"e2202206","DOI":"10.1002\/advs.202202206","volume":"9","author":"C Zhong","year":"2022","unstructured":"Zhong C, Niu Y, Liu W, Yuan Y, Li K, Shi Y, Qiu Z, Li K, Lin Z, Huang Z, Zuo D, Yang Z, Liao Y, Zhang Y, Wang C, Qiu J, He W, Yuan Y, Li B (2022) S100A9 Derived from Chemoembolization-Induced Hypoxia governs mitochondrial function in Hepatocellular Carcinoma Progression. Adv Sci (Weinheim Baden-Wurttemberg Germany) 9(30):e2202206. https:\/\/doi.org\/10.1002\/advs.202202206","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"1995_CR10","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/IJN.S295565","volume":"16","author":"P Zhao","year":"2021","unstructured":"Zhao P, Qiu L, Zhou S, Li L, Qian Z, Zhang H (2021) Cancer Cell membrane camouflaged mesoporous silica nanoparticles combined with Immune Checkpoint Blockade for regulating Tumor Microenvironment and Enhancing Antitumor Therapy. Int J Nanomed 16:2107\u20132121. https:\/\/doi.org\/10.2147\/IJN.S295565","journal-title":"Int J Nanomed"},{"issue":"2","key":"1995_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP (2015) Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161(2):205\u2013214. https:\/\/doi.org\/10.1016\/j.cell.2015.03.030","journal-title":"Cell"},{"key":"1995_CR12","doi-asserted-by":"publisher","first-page":"1125093","DOI":"10.3389\/fphar.2023.1125093","volume":"14","author":"A Fernandez-Fernandez","year":"2023","unstructured":"Fernandez-Fernandez A, Manchanda R, Kumari M (2023) Lipid-engineered nanotherapeutics for cancer management. Front Pharmacol 14:1125093. https:\/\/doi.org\/10.3389\/fphar.2023.1125093","journal-title":"Front Pharmacol"},{"issue":"3","key":"1995_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ccell.2022.01.006","volume":"40","author":"MP Vincent","year":"2022","unstructured":"Vincent MP, Navidzadeh JO, Bobbala S, Scott EA (2022) Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy. Cancer Cell 40(3):255\u2013276. https:\/\/doi.org\/10.1016\/j.ccell.2022.01.006","journal-title":"Cancer Cell"},{"issue":"7","key":"1995_CR14","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1021\/acsbiomaterials.3c00255","volume":"9","author":"S Dabagh","year":"2023","unstructured":"Dabagh S, Haris SA, Ertas YN (2023) Engineered Polyethylene Glycol-Coated Zinc Ferrite nanoparticles as a Novel magnetic resonance imaging contrast Agent. ACS Biomaterials Sci Eng 9(7):4138\u20134148. https:\/\/doi.org\/10.1021\/acsbiomaterials.3c00255","journal-title":"ACS Biomaterials Sci Eng"},{"issue":"9","key":"1995_CR15","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/nano11092190","volume":"11","author":"LM Shaker","year":"2021","unstructured":"Shaker LM, Alamiery A, Takriff M, Wan Isahak WNR (2021) Novel Blue-Wavelength-Blocking Contact Lens with Er3+\/TiO2 NPs: manufacture and characterization. Nanomaterials (Basel Switzerland) 11(9):2190. https:\/\/doi.org\/10.3390\/nano11092190","journal-title":"Nanomaterials (Basel Switzerland)"},{"issue":"6383","key":"1995_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/358209a0","volume":"358","author":"XM He","year":"1992","unstructured":"He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358(6383):209\u2013215. https:\/\/doi.org\/10.1038\/358209a0","journal-title":"Nature"},{"issue":"3","key":"1995_CR17","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1039\/c6sc03862j","volume":"8","author":"J Mayr","year":"2017","unstructured":"Mayr J, Heffeter P, Groza D, Galvez L, Koellensperger G, Roller A, Alte B, Haider M, Berger W, Kowol CR, Keppler BK (2017) An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo. Chem Sci 8(3):2241\u20132250. https:\/\/doi.org\/10.1039\/c6sc03862j","journal-title":"Chem Sci"},{"issue":"31","key":"1995_CR18","doi-asserted-by":"publisher","first-page":"17377","DOI":"10.1021\/jacs.3c05052","volume":"145","author":"WT Dou","year":"2023","unstructured":"Dou WT, Qiu P, Shi Y, Zhu L, Guo C, Li N, Zang Y, Liu T, Zhao S, Pan Y, Dong L, Sessler JL, Tan Y, Li J, Wang H, Tian H, He XP (2023) Orthogonally Engineered Albumin with attenuated macrophage phagocytosis for the targeted visualization and phototherapy of Liver Cancer. J Am Chem Soc 145(31):17377\u201317388. https:\/\/doi.org\/10.1021\/jacs.3c05052","journal-title":"J Am Chem Soc"},{"issue":"1","key":"1995_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ijms24010095","volume":"24","author":"KD Moudgil","year":"2022","unstructured":"Moudgil KD, Venkatesha SH (2022) The anti-inflammatory and immunomodulatory activities of Natural products to control autoimmune inflammation. Int J Mol Sci 24(1):95. https:\/\/doi.org\/10.3390\/ijms24010095","journal-title":"Int J Mol Sci"},{"key":"1995_CR20","doi-asserted-by":"publisher","unstructured":"Zhang LX, Li CX, Kakar MU, Khan MS, Wu PF, Amir RM, Dai DF, Naveed M, Li QY, Saeed M, Shen JQ, Rajput SA, Li JH (2021) Resveratrol (RV): a pharmacological review and call for further research, vol 143. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie, p 112164. https:\/\/doi.org\/10.1016\/j.biopha.2021.112164","DOI":"10.1016\/j.biopha.2021.112164"},{"key":"1995_CR21","doi-asserted-by":"publisher","first-page":"145968","DOI":"10.1016\/j.gene.2021.145968","volume":"808","author":"T Li","year":"2022","unstructured":"Li T, Tan Y, Ouyang S, He J, Liu L (2022) Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene 808:145968. https:\/\/doi.org\/10.1016\/j.gene.2021.145968","journal-title":"Gene"},{"key":"1995_CR22","unstructured":"Nobel JJ, Mosenkis R (1970) Hospital emergency command system. Hospitals, 44(16)"},{"issue":"2","key":"1995_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0006-8993(79)91007-2","volume":"175","author":"J Gazendam","year":"1979","unstructured":"Gazendam J, Go KG, van Zanten AK (1979) The effect of intracerebral ouabain administration on the composition of edema fluid isolated from cats with cold-induced brain edema. Brain Res 175(2):279\u2013290. https:\/\/doi.org\/10.1016\/0006-8993(79)91007-2","journal-title":"Brain Res"},{"issue":"18","key":"1995_CR24","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.7150\/thno.74974","volume":"12","author":"C Wu","year":"2022","unstructured":"Wu C, Dai C, Li X, Sun M, Chu H, Xuan Q, Yin Y, Fang C, Yang F, Jiang Z, Lv Q, He K, Qu Y, Zhao B, Cai K, Zhang S, Sun R, Xu G, Zhang L, Sun S, Liu Y (2022) AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy. Theranostics 12(18):7681\u20137698. https:\/\/doi.org\/10.7150\/thno.74974","journal-title":"Theranostics"},{"issue":"6","key":"1995_CR25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mc.23527","volume":"62","author":"J Chen","year":"2023","unstructured":"Chen J, Zhang J, Tian W, Ge C, Su Y, Li J, Tian H (2023) AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP\/SLC7A11 signaling pathway. Mol Carcinog 62(6):833\u2013844. https:\/\/doi.org\/10.1002\/mc.23527","journal-title":"Mol Carcinog"},{"issue":"3","key":"1995_CR26","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.18632\/aging.202380","volume":"13","author":"P Zhu","year":"2021","unstructured":"Zhu P, Feng R, Lu X, Liao Y, Du Z, Zhai W, Chen K (2021) Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma. Aging 13(3):4138\u20134156. https:\/\/doi.org\/10.18632\/aging.202380","journal-title":"Aging"},{"issue":"5","key":"1995_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-20-2480","volume":"81","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Tian W, Jiang Z, Huang T, Ge C, Liu T, Zhao F, Chen T, Cui Y, Li H, Yao M, Li J, Tian H (2021) A positive Feedback Loop of AKR1C3-Mediated activation of NF-\u03baB and STAT3 facilitates proliferation and metastasis in Hepatocellular Carcinoma. Cancer Res 81(5):1361\u20131374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2480","journal-title":"Cancer Res"},{"key":"1995_CR28","doi-asserted-by":"publisher","first-page":"632042","DOI":"10.3389\/fonc.2022.632042","volume":"12","author":"T Deng","year":"2022","unstructured":"Deng T, Liu Y, Zhuang J, Tang Y, Huo Q (2022) ASPM is a prognostic biomarker and correlates with Immune infiltration in kidney renal clear cell carcinoma and liver Hepatocellular Carcinoma. Front Oncol 12:632042. https:\/\/doi.org\/10.3389\/fonc.2022.632042","journal-title":"Front Oncol"},{"issue":"1","key":"1995_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1039\/d2bm01691e","volume":"11","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wang Z, Xiong Y, Wang C, Deng Q, Yang T, Xu Q, Yong Z, Yang X, Li Z (2022) A two-pronged strategy to alleviate tumor hypoxia and potentiate photodynamic therapy by mild hyperthermia. Biomaterials Sci 11(1):108\u2013118. https:\/\/doi.org\/10.1039\/d2bm01691e","journal-title":"Biomaterials Sci"},{"key":"1995_CR30","doi-asserted-by":"publisher","unstructured":"Liang L, Wang Y, Zhang C, Chang Y, Wang Y, Xue J, Wang L, Zhang F, Niu K (2023) Oxygen self-supplied nanoparticle for enhanced chemiexcited photodynamic therapy. Biomedical Mater (Bristol England) 19(1). https:\/\/doi.org\/10.1088\/1748-605X\/ad15e2","DOI":"10.1088\/1748-605X\/ad15e2"},{"key":"1995_CR31","doi-asserted-by":"publisher","first-page":"1074271","DOI":"10.3389\/fimmu.2022.1074271","volume":"13","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Fu M, Li N, Ye M (2022) Identification of immune infiltration and cuproptosis-related subgroups in Crohn\u2019s disease. Front Immunol 13:1074271. https:\/\/doi.org\/10.3389\/fimmu.2022.1074271","journal-title":"Front Immunol"},{"key":"1995_CR32","doi-asserted-by":"publisher","first-page":"1062590","DOI":"10.3389\/fimmu.2023.1062590","volume":"14","author":"X Gao","year":"2023","unstructured":"Gao X, Guo Z, Wang P, Liu Z, Wang Z (2023) Transcriptomic analysis reveals the potential crosstalk genes and immune relationship between IgA nephropathy and periodontitis. Front Immunol 14:1062590. https:\/\/doi.org\/10.3389\/fimmu.2023.1062590","journal-title":"Front Immunol"},{"key":"1995_CR33","doi-asserted-by":"publisher","first-page":"1047930","DOI":"10.3389\/fimmu.2022.1047930","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Sun X, Tan S, Luo C, Zhou J, Zhang S, Li Z, Lin H, Zhang W (2022) M2 macrophage-related gene signature in chronic rhinosinusitis with nasal polyps. Front Immunol 13:1047930. https:\/\/doi.org\/10.3389\/fimmu.2022.1047930","journal-title":"Front Immunol"},{"issue":"18","key":"1995_CR34","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi L, Rastelli G (2019) Molecular Docking: shifting paradigms in Drug Discovery. Int J Mol Sci 20(18):4331. https:\/\/doi.org\/10.3390\/ijms20184331","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1995_CR35","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1995_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/diagnostics10030171","volume":"10","author":"YJ Deng","year":"2020","unstructured":"Deng YJ, Ren EH, Yuan WH, Zhang GZ, Wu ZL, Xie QQ (2020) GRB10 and E2F3 as diagnostic markers of Osteoarthritis and their correlation with Immune Infiltration. Diagnostics (Basel Switzerland) 10(3):171. https:\/\/doi.org\/10.3390\/diagnostics10030171","journal-title":"Diagnostics (Basel Switzerland)"},{"issue":"9","key":"1995_CR37","doi-asserted-by":"publisher","first-page":"16540","DOI":"10.1002\/jcp.28324","volume":"234","author":"XY Peng","year":"2019","unstructured":"Peng XY, Wang Y, Hu H, Zhang XJ, Li Q (2019) Identification of the molecular subgroups in coronary artery disease by gene expression profiles. J Cell Physiol 234(9):16540\u201316548. https:\/\/doi.org\/10.1002\/jcp.28324","journal-title":"J Cell Physiol"},{"key":"1995_CR38","doi-asserted-by":"publisher","first-page":"1015882","DOI":"10.3389\/fimmu.2022.1015882","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Huang Z, Xiao Y, Wan W, Yang X (2022) The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysis. Front Immunol 13:1015882. https:\/\/doi.org\/10.3389\/fimmu.2022.1015882","journal-title":"Front Immunol"},{"issue":"2","key":"1995_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/cancers15020553","volume":"15","author":"X Bian","year":"2023","unstructured":"Bian X, Yin S, Yin X, Fang T, Wang Y, Yang S, Jiang X, Xue Y, Ye F, Zhang L (2023) Clinical and biological significances of FBLN5 in gastric Cancer. Cancers 15(2):553. https:\/\/doi.org\/10.3390\/cancers15020553","journal-title":"Cancers"},{"issue":"23","key":"1995_CR40","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.26355\/eurrev_202112_27449","volume":"25","author":"A Pilipovi\u0107","year":"2021","unstructured":"Pilipovi\u0107 A, Mitrovi\u0107 D, Obradovi\u0107 S, Po\u0161a M (2021) Docking-based analysis and modeling of the activity of bile acids and their synthetic analogues on large conductance Ca2\u2009+\u2009activated K channels in smooth muscle cells. Eur Rev Med Pharmacol Sci 25(23):7501\u20137507. https:\/\/doi.org\/10.26355\/eurrev_202112_27449","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"1995_CR41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1523\/JNEUROSCI.2262-16.2016","volume":"37","author":"BC Jiang","year":"2017","unstructured":"Jiang BC, He LN, Wu XB, Shi H, Zhang WW, Zhang ZJ, Cao DL, Li CH, Gu J, Gao YJ (2017) Promoted Interaction of C\/EBP\u03b1 with demethylated Cxcr3 gene promoter contributes to Neuropathic Pain in mice. J Neuroscience: Official J Soc Neurosci 37(3):685\u2013700. https:\/\/doi.org\/10.1523\/JNEUROSCI.2262-16.2016","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"issue":"1","key":"1995_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-020-01249-8","volume":"19","author":"M Wang","year":"2020","unstructured":"Wang M, Liu J, Zhao Y, He R, Xu X, Guo X, Li X, Xu S, Miao J, Guo J, Zhang H, Gong J, Zhu F, Tian R, Shi C, Peng F, Feng Y, Yu S, Xie Y, Jiang J, Qin R (2020) Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer 19(1):130. https:\/\/doi.org\/10.1186\/s12943-020-01249-8","journal-title":"Mol Cancer"},{"issue":"1","key":"1995_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13287-021-02681-3","volume":"13","author":"M Charrier","year":"2022","unstructured":"Charrier M, Lorant J, Contreras-Lopez R, T\u00e9j\u00e9dor G, Blanquart C, Lieubeau B, Schleder C, Leroux I, Deshayes S, Fonteneau JF, Babarit C, Hamel A, Magot A, P\u00e9r\u00e9on Y, Viau S, Delorme B, Luz-Crawford P, Lamirault G, Djouad F, Rouger K (2022) Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways. Stem Cell Res Ther 13(1):7. https:\/\/doi.org\/10.1186\/s13287-021-02681-3","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1995_CR44","doi-asserted-by":"publisher","first-page":"1736792","DOI":"10.1080\/2162402X.2020.1736792","volume":"9","author":"N Gestermann","year":"2020","unstructured":"Gestermann N, Saugy D, Martignier C, Till\u00e9 L, Fuertes Marraco SA, Zettl M, Tirapu I, Speiser DE, Verdeil G (2020) LAG-3 and PD-1\u2009+\u2009LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma\/T cell co-cultures. Oncoimmunology 9(1):1736792. https:\/\/doi.org\/10.1080\/2162402X.2020.1736792","journal-title":"Oncoimmunology"},{"issue":"18","key":"1995_CR45","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2217\/nnm-2020-0156","volume":"15","author":"A Saraswat","year":"2020","unstructured":"Saraswat A, Patki M, Fu Y, Barot S, Dukhande VV, Patel K (2020) Nanoformulation of PROteolysis TArgeting chimera targeting \u2018undruggable\u2019 c-Myc for the treatment of pancreatic cancer. Nanomed (London England) 15(18):1761\u20131777. https:\/\/doi.org\/10.2217\/nnm-2020-0156","journal-title":"Nanomed (London England)"},{"issue":"1","key":"1995_CR46","doi-asserted-by":"publisher","first-page":"e08702","DOI":"10.1016\/j.heliyon.2021.e08702","volume":"8","author":"A Saraswat","year":"2022","unstructured":"Saraswat A, Vemana HP, Dukhande VV, Patel K (2022) Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy. Heliyon 8(1):e08702. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08702","journal-title":"Heliyon"},{"issue":"1","key":"1995_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13287-020-01881-7","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, Shen H, Shao L, Teng X, Chen Y, Liu X, Yang Z, Shen Z (2020) HIF-1\u03b1 overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis. Stem Cell Res Ther 11(1):373. https:\/\/doi.org\/10.1186\/s13287-020-01881-7","journal-title":"Stem Cell Res Ther"},{"key":"1995_CR48","doi-asserted-by":"publisher","first-page":"11507","DOI":"10.2147\/OTT.S222564","volume":"12","author":"L Liu","year":"2019","unstructured":"Liu L, Xie D, Xie H, Huang W, Zhang J, Jin W, Jiang W, Xie D (2019) ARHGAP10 inhibits the proliferation and metastasis of CRC cells via blocking the activity of RhoA\/AKT signaling pathway. OncoTargets Therapy 12:11507\u201311516. https:\/\/doi.org\/10.2147\/OTT.S222564","journal-title":"OncoTargets Therapy"},{"key":"1995_CR49","doi-asserted-by":"publisher","unstructured":"Zhang Z, Li W, Jiang D, Liu C, Lai Z (2020) MicroRNA-139-5p inhibits cell viability, migration and invasion and suppresses tumor growth by targeting HDGF in non-small cell lung cancer. Oncology letters, 19(3), 1806\u20131814. https:\/\/doi.org\/10.3892\/ol.2020.11296 (Retraction published Oncol Lett. 2023;26(6):503. doi: 10.3892\/ol.2023.14090)","DOI":"10.3892\/ol.2020.11296"},{"issue":"1","key":"1995_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7150\/thno.16803","volume":"7","author":"SC Guo","year":"2017","unstructured":"Guo SC, Tao SC, Yin WJ, Qi X, Yuan T, Zhang CQ (2017) Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics 7(1):81\u201396. https:\/\/doi.org\/10.7150\/thno.16803","journal-title":"Theranostics"},{"issue":"151","key":"1995_CR51","doi-asserted-by":"publisher","first-page":"20180709","DOI":"10.1098\/rsif.2018.0709","volume":"16","author":"AVP Bobadilla","year":"2019","unstructured":"Bobadilla AVP, Ar\u00e9valo J, Sarr\u00f3 E, Byrne HM, Maini PK, Carraro T, Balocco S, Meseguer A, Alarc\u00f3n T (2019) In vitro cell migration quantification method for scratch assays. J R Soc Interface 16(151):20180709. https:\/\/doi.org\/10.1098\/rsif.2018.0709","journal-title":"J R Soc Interface"},{"issue":"11","key":"1995_CR52","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1038\/s41418-021-00804-0","volume":"28","author":"Y Hou","year":"2021","unstructured":"Hou Y, Zhang Q, Pang W, Hou L, Liang Y, Han X, Luo X, Wang P, Zhang X, Li L, Meng X (2021) YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect. Cell Death Differ 28(11):3105\u20133124. https:\/\/doi.org\/10.1038\/s41418-021-00804-0","journal-title":"Cell Death Differ"},{"key":"1995_CR53","doi-asserted-by":"publisher","unstructured":"Zhao, W., Zhang, L., Zhang, Y., Jiang, Z., Lu, H., Xie, Y., Han, W., Zhao, W., He, J., Shi, Z., Yang, H., Chen, J., Chen, S., Li, Z., Mao, J., Zhou, L., Gao, X., Li, W., Tan, G., Zhang, B., ? Wang, Z. (2023). The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest. Cell death & disease, 14(1), 11. https:\/\/doi.org\/10.1038\/s41419-022-05528-8","DOI":"10.1038\/s41419-022-05528-8"},{"issue":"1","key":"1995_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41420-021-00626-6","volume":"7","author":"S Wang","year":"2021","unstructured":"Wang S, Su T, Tong H, Zhou D, Ma F, Ding J, Hao Y, Shi W, Quan Z (2021) Circ\u03b2-catenin promotes tumor growth and Warburg effect of gallbladder cancer by regulating STMN1 expression. Cell Death Discovery 7(1):233. https:\/\/doi.org\/10.1038\/s41420-021-00626-6","journal-title":"Cell Death Discovery"},{"issue":"2","key":"1995_CR55","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.fm.2013.06.013","volume":"36","author":"N Desriac","year":"2013","unstructured":"Desriac N, Postollec F, Durand D, Leguerinel I, Sohier D, Coroller L (2013) Sensitivity of Bacillus weihenstephanensis to acidic changes of the medium is not dependant on physiological state. Food Microbiol 36(2):440\u2013446. https:\/\/doi.org\/10.1016\/j.fm.2013.06.013","journal-title":"Food Microbiol"},{"issue":"1","key":"1995_CR56","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12951-021-01034-9","volume":"19","author":"S Wang","year":"2021","unstructured":"Wang S, Zhou X, Zeng Z, Sui M, Chen L, Feng C, Huang C, Yang Q, Ji M, Hou P (2021) Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment. J Nanobiotechnol 19(1):302. https:\/\/doi.org\/10.1186\/s12951-021-01034-9","journal-title":"J Nanobiotechnol"},{"key":"1995_CR57","doi-asserted-by":"publisher","unstructured":"Qu Y, Chu B, Wei X, Chen Y, Yang Y, Hu D, Huang J, Wang F, Chen M, Zheng Y, Qian Z (2022) Cancer-Cell-Biomimetic nanoparticles for targeted therapy of multiple myeloma based on bone marrow homing. Advanced materials (Deerfield Beach, Fla. 34(46):e2107883. https:\/\/doi.org\/10.1002\/adma.202107883","DOI":"10.1002\/adma.202107883"},{"issue":"3","key":"1995_CR58","first-page":"301","volume":"48","author":"S Ono","year":"1978","unstructured":"Ono S, Hirano H, Obara K (1978) Effect of calcium ion on the cortisol-binding protein in the lens and blood plasma. International journal for vitamin and nutrition research. Internationale Zeitschrift fur vitamin- und Ernahrungsforschung. J Int de Vitaminologie et de Nutr 48(3):301\u2013303","journal-title":"J Int de Vitaminologie et de Nutr"},{"issue":"11","key":"1995_CR59","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1023\/b:pham.0000003390.51761.3d","volume":"20","author":"B DeSilva","year":"2003","unstructured":"DeSilva B, Smith W, Weiner R, Kelley M, Smolec J, Lee B, Khan M, Tacey R, Hill H, Celniker A (2003) Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res 20(11):1885\u20131900. https:\/\/doi.org\/10.1023\/b:pham.0000003390.51761.3d","journal-title":"Pharm Res"},{"key":"1995_CR60","doi-asserted-by":"publisher","first-page":"101477","DOI":"10.1016\/j.jddst.2020.101477","volume":"55","author":"AL Saraswat","year":"2020","unstructured":"Saraswat AL, Maher TJ (2020) Development and optimization of stealth liposomal system for enhanced in vitro cytotoxic effect of quercetin. J Drug Deliv Sci Technol 55:101477. https:\/\/doi.org\/10.1016\/j.jddst.2020.101477","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"1995_CR61","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1002\/cam4.1682","volume":"7","author":"R Liu","year":"2018","unstructured":"Liu R, Guo H, Lu S (2018) MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2. Cancer Med 7(9):4598\u20134609. https:\/\/doi.org\/10.1002\/cam4.1682","journal-title":"Cancer Med"},{"issue":"1","key":"1995_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","volume":"53","author":"X Pan","year":"2021","unstructured":"Pan X, Hong X, Li S, Meng P, Xiao F (2021) METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner. Exp Mol Med 53(1):91\u2013102. https:\/\/doi.org\/10.1038\/s12276-020-00510-w","journal-title":"Exp Mol Med"},{"issue":"1","key":"1995_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12964-019-0430-7","volume":"17","author":"S Saraswati","year":"2019","unstructured":"Saraswati S, Alhaider A, Abdelgadir AM, Tanwer P, Korashy HM (2019) Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt\/VEGFR2 pathway in hepatocellular carcinoma. Cell Communication Signaling: CCS 17(1):127. https:\/\/doi.org\/10.1186\/s12964-019-0430-7","journal-title":"Cell Communication Signaling: CCS"},{"key":"1995_CR64","doi-asserted-by":"publisher","first-page":"105824","DOI":"10.1016\/j.intimp.2019.105824","volume":"75","author":"M Ke","year":"2019","unstructured":"Ke M, Zhang Z, Xu B, Zhao S, Ding Y, Wu X, Wu R, Lv Y, Dong J (2019) Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells. Int Immunopharmacol 75:105824. https:\/\/doi.org\/10.1016\/j.intimp.2019.105824","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1995_CR65","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12951-022-01554-y","volume":"20","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Jia R, Li J, Tian X, Qian Y (2022) Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma. J Nanobiotechnol 20(1):339. https:\/\/doi.org\/10.1186\/s12951-022-01554-y","journal-title":"J Nanobiotechnol"},{"key":"1995_CR66","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ebiom.2018.04.026","volume":"31","author":"F Han","year":"2018","unstructured":"Han F, Liu WB, Shi XY, Yang JT, Zhang X, Li ZM, Jiang X, Yin L, Li JJ, Huang CS, Cao J, Liu JY (2018) SOX30 inhibits Tumor Metastasis through attenuating wnt-signaling via Transcriptional and Posttranslational Regulation of \u03b2-Catenin in Lung Cancer. EBioMedicine 31:253\u2013266. https:\/\/doi.org\/10.1016\/j.ebiom.2018.04.026","journal-title":"EBioMedicine"},{"issue":"1","key":"1995_CR67","doi-asserted-by":"publisher","first-page":"1829346","DOI":"10.1080\/2162402X.2020.1829346","volume":"9","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Huang H, Zheng F, Liu H, Qiu F, Chen Y, Liang CL, Dai Z (2020) Resveratrol exerts antitumor effects by downregulating CD8+CD122+ Tregs in murine hepatocellular carcinoma. Oncoimmunology 9(1):1829346. https:\/\/doi.org\/10.1080\/2162402X.2020.1829346","journal-title":"Oncoimmunology"},{"issue":"2","key":"1995_CR68","doi-asserted-by":"publisher","first-page":"e2101946","DOI":"10.1002\/adhm.202101946","volume":"11","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xin L, Li J, Cao J, Sun Y, Wang X, Luo J, Zeng Y, Li Q, Zhang Y, Zhang T, Huang P (2022) Metal-Organic Framework (MOF)-Based Ultrasound-Responsive Dual-Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy. Adv Healthc Mater 11(2):e2101946. https:\/\/doi.org\/10.1002\/adhm.202101946","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"1995_CR69","doi-asserted-by":"publisher","first-page":"2225884","DOI":"10.1080\/15384047.2023.2225884","volume":"24","author":"P Wang","year":"2023","unstructured":"Wang P, Sun J, Sun C, Zhao H, Zhang Y, Chen J (2023) BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1. Cancer Biol Ther 24(1):2225884. https:\/\/doi.org\/10.1080\/15384047.2023.2225884","journal-title":"Cancer Biol Ther"},{"issue":"10360","key":"1995_CR70","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A (2022) Hepatocellular carcinoma. Lancet (London England) 400(10360):1345\u20131362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4","journal-title":"Lancet (London England)"},{"key":"1995_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res 149:1\u201361. https:\/\/doi.org\/10.1016\/bs.acr.2020.10.001","journal-title":"Adv Cancer Res"},{"issue":"15","key":"1995_CR72","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2174\/0929867331666230914090053","volume":"31","author":"K Tong","year":"2024","unstructured":"Tong K, Wang P, Li Y, Tong Y, Li X, Yan S, Hu P (2024) Resveratrol Inhibits Hepatocellular Carcinoma Progression through regulating Exosome Secretion. Curr Med Chem 31(15):2107\u20132118. https:\/\/doi.org\/10.2174\/0929867331666230914090053","journal-title":"Curr Med Chem"},{"key":"1995_CR73","doi-asserted-by":"publisher","first-page":"914032","DOI":"10.3389\/fonc.2022.914032","volume":"12","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Mobashir M, Al-Keridis LA, Alshammari N, Adnan M, Abid M, Hassan MI (2022) A network-guided Approach to Discover Phytochemical-based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma. Front Oncol 12:914032. https:\/\/doi.org\/10.3389\/fonc.2022.914032","journal-title":"Front Oncol"},{"issue":"3","key":"1995_CR74","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1080\/07391102.2020.1824811","volume":"40","author":"I Malami","year":"2022","unstructured":"Malami I, Bunza AM, Alhassan AM, Muhammad A, Abubakar IB, Yunusa A, Waziri PM, Etti IC (2022) Dihydroartemisinin as a potential drug candidate for cancer therapy: a structural-based virtual screening for multitarget profiling. J Biomol Struct Dyn 40(3):1347\u20131362. https:\/\/doi.org\/10.1080\/07391102.2020.1824811","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"1995_CR75","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/cells10071715","volume":"10","author":"MH Bao","year":"2021","unstructured":"Bao MH, Wong CC (2021) Hypoxia, metabolic reprogramming, and Drug Resistance in Liver Cancer. Cells 10(7):1715. https:\/\/doi.org\/10.3390\/cells10071715","journal-title":"Cells"},{"key":"1995_CR76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fphys.2014.00299","volume":"5","author":"AM Merlot","year":"2014","unstructured":"Merlot AM, Kalinowski DS, Richardson DR (2014) Unraveling the mysteries of serum albumin-more than just a serum protein. Front Physiol 5:299. https:\/\/doi.org\/10.3389\/fphys.2014.00299","journal-title":"Front Physiol"},{"issue":"1\u20132","key":"1995_CR77","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijpharm.2012.12.035","volume":"443","author":"L Jiang","year":"2013","unstructured":"Jiang L, Xu Y, Liu Q, Tang Y, Ge L, Zheng C, Zhu J, Liu J (2013) A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: formation dynamics, influencing factors and formation mechanisms investigation. Int J Pharm 443(1\u20132):80\u201386. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.12.035","journal-title":"Int J Pharm"},{"issue":"4","key":"1995_CR78","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/cancers14040877","volume":"14","author":"V Rapozzi","year":"2022","unstructured":"Rapozzi V, Moret F, Menilli L, Guerrini A, Tedesco D, Naldi M, Bartolini M, Gani M, Zorzet S, Columbaro M, Milani C, Martini C, Ferroni C, Varchi G (2022) HSA-Binding prodrugs-based nanoparticles endowed with chemo and photo-toxicity against breast Cancer. Cancers 14(4):877. https:\/\/doi.org\/10.3390\/cancers14040877","journal-title":"Cancers"},{"key":"1995_CR79","doi-asserted-by":"publisher","unstructured":"Kumbham S, Ghosh A, Ghosh B, Biswas S (2022) Human serum albumin-poly(Lactide)-conjugated self-assembly NPs for targeted docetaxel delivery and improved therapeutic efficacy in oral cancer. Int J Biol Macromol 222(Pt A 1287\u20131303. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.250","DOI":"10.1016\/j.ijbiomac.2022.09.250"},{"issue":"1","key":"1995_CR80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","volume":"83","author":"M Huang","year":"2023","unstructured":"Huang M, Long J, Yao Z, Zhao Y, Zhao Y, Liao J, Lei K, Xiao H, Dai Z, Peng S, Lin S, Xu L, Kuang M (2023) METTL1-Mediated m7G tRNA modification promotes Lenvatinib Resistance in Hepatocellular Carcinoma. Cancer Res 83(1):89\u2013102. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0963","journal-title":"Cancer Res"},{"issue":"30","key":"1995_CR81","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41388-023-02751-1","volume":"42","author":"L Wang","year":"2023","unstructured":"Wang L, Li G, Zhou Z, Ge C, Chen Q, Liu Y, Zhang N, Zhang K, Niu M, Li W, Zhong X, Wu S, Zhang J, Liu Y (2023) Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263. Oncogene 42(30):2329\u20132346. https:\/\/doi.org\/10.1038\/s41388-023-02751-1","journal-title":"Oncogene"},{"issue":"1","key":"1995_CR82","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/jcm12010223","volume":"12","author":"G Capriotti","year":"2022","unstructured":"Capriotti G, Piccardo A, Giovannelli E, Signore A (2022) Targeting copper in Cancer Imaging and Therapy: a New Theragnostic Agent. J Clin Med 12(1):223. https:\/\/doi.org\/10.3390\/jcm12010223","journal-title":"J Clin Med"},{"issue":"1","key":"1995_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13062-023-00370-0","volume":"18","author":"C Liu","year":"2023","unstructured":"Liu C, Xu K, Liu J, He C, Liu P, Fu Q, Zhang H, Qin T (2023) LncRNA RP11-620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326\/GPI to enhance glycolysis. Biol Direct 18(1):15. https:\/\/doi.org\/10.1186\/s13062-023-00370-0","journal-title":"Biol Direct"},{"issue":"1","key":"1995_CR84","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","volume":"80","author":"L Zhang","year":"2024","unstructured":"Zhang L, Xu J, Zhou S, Yao F, Zhang R, You W, Dai J, Yu K, Zhang Y, Baheti T, Pu L, Xu J, Qian X, Zhang C, Xia Y, Dai X, Li Q, Wang X (2024) Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. J Hepatol 80(1):82\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.006","journal-title":"J Hepatol"},{"issue":"8","key":"1995_CR85","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","volume":"73","author":"U Prabhakar","year":"2013","unstructured":"Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC (2013) Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 73(8):2412\u20132417. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4561","journal-title":"Cancer Res"},{"issue":"4","key":"1995_CR86","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2174\/1389200221666201124123939","volume":"22","author":"A Sharma","year":"2021","unstructured":"Sharma A, Manchanda R, Pottoo FH, Ashraf GM (2021) Nano-Neurotherapeutics (NNTs): an Emergent and Multifaceted Tool for CNS disorders. Curr Drug Metab 22(4):251\u2013262. https:\/\/doi.org\/10.2174\/1389200221666201124123939","journal-title":"Curr Drug Metab"},{"issue":"1","key":"1995_CR87","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-023-01797-9","volume":"22","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li S (2023) Nanomaterials in tumor immunotherapy: new strategies and challenges. Mol Cancer 22(1):94. https:\/\/doi.org\/10.1186\/s12943-023-01797-9","journal-title":"Mol Cancer"},{"issue":"1","key":"1995_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","volume":"41","author":"N Kumari","year":"2022","unstructured":"Kumari N, Choi SH (2022) Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies. J Experimental Clin cancer Research: CR 41(1):68. https:\/\/doi.org\/10.1186\/s13046-022-02272-x","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"1","key":"1995_CR89","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12951-023-01909-z","volume":"21","author":"Y Dutt","year":"2023","unstructured":"Dutt Y, Pandey RP, Dutt M, Gupta A, Vibhuti A, Vidic J, Raj VS, Chang CM, Priyadarshini A (2023) Therapeutic applications of nanobiotechnology. J Nanobiotechnol 21(1):148. https:\/\/doi.org\/10.1186\/s12951-023-01909-z","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1995_CR90","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/10717544.2019.1704944","volume":"27","author":"M Wu","year":"2020","unstructured":"Wu M, Zhong C, Deng Y, Zhang Q, Zhang X, Zhao X (2020) Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability. Drug Delivery 27(1):81\u201390. https:\/\/doi.org\/10.1080\/10717544.2019.1704944","journal-title":"Drug Delivery"},{"key":"1995_CR91","doi-asserted-by":"publisher","unstructured":"Long Q, Zhu W, Guo L et al (2020) RGD-conjugated resveratrol HSA nanoparticles as a novel delivery system in ovarian cancer therapy. Drug Design, Development and Therapy, 2020, 5747\u20135756. https:\/\/doi.org\/10.2147\/DDDT.S276924","DOI":"10.2147\/DDDT.S276924"},{"issue":"12","key":"1995_CR92","doi-asserted-by":"publisher","first-page":"11717","DOI":"10.18632\/aging.103357","volume":"12","author":"H Dai","year":"2020","unstructured":"Dai H, Li M, Yang W et al (2020) Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN\/AKT signaling. Aging 12(12):11717\u201311732. https:\/\/doi.org\/10.18632\/aging.103357","journal-title":"Aging"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-01995-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-024-01995-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-01995-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T18:05:55Z","timestamp":1726941955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-024-01995-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":92,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1995"],"URL":"https:\/\/doi.org\/10.1007\/s10495-024-01995-w","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"24 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were approved by The First Affiliated Hospital of Jinzhou Medical University\u2019s Animal Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}